150 related articles for article (PubMed ID: 30147087)
41. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
42. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
43. BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment.
Geisler CH; Hansen MM; Andersen NS; Brown P; Christensen LD; Dickmeiss E; Ersbøll J; Myhre J; Hansen M; Juhl BR; Mortensen BT; Pedersen-Bjergaard J
Eur J Haematol; 1998 Sep; 61(3):173-82. PubMed ID: 9753413
[TBL] [Abstract][Full Text] [Related]
44. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
45. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
46. Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
Nachbaur D; Greinix HT; Koller E; Krieger O; Linkesch W; Kasparu H; Pober M; Hinterberger W; Hausmaninger H; Heistinger M; Ulsperger E; Karlhuber S; Schwinger W; Lindner B
Ann Hematol; 2005 Jul; 84(7):462-73. PubMed ID: 15726362
[TBL] [Abstract][Full Text] [Related]
47. Pemphigus and hematologic malignancies: A population-based study of 11,859 patients.
Kridin K; Zelber-Sagi S; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2018 Jun; 78(6):1084-1089.e1. PubMed ID: 29198780
[TBL] [Abstract][Full Text] [Related]
48. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
[TBL] [Abstract][Full Text] [Related]
49. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
[TBL] [Abstract][Full Text] [Related]
50. Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience.
Wali R; Saeed H; Patrus N; Javed S; Khan SJ
J Glob Oncol; 2019 Nov; 5():1-6. PubMed ID: 31756138
[TBL] [Abstract][Full Text] [Related]
51. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
Idris M; Shah SH; Fareed J; Gul N
J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
[TBL] [Abstract][Full Text] [Related]
52. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
53. Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation.
Dorr RT; Briggs A; Kintzel P; Meyers R; Chow HH; List A
Bone Marrow Transplant; 2003 Apr; 31(8):643-9. PubMed ID: 12692603
[TBL] [Abstract][Full Text] [Related]
54. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation.
Jones RJ; Ambinder RF; Piantadosi S; Santos GW
Blood; 1991 Feb; 77(3):649-53. PubMed ID: 1991174
[TBL] [Abstract][Full Text] [Related]
55. [Therapy in Hodgkin disease and non-Hodgkin lymphomas].
Sréter L
Orv Hetil; 2009 Apr; 150(14):651-5. PubMed ID: 19318337
[TBL] [Abstract][Full Text] [Related]
56. Mortality patterns among recipients of autologous hematopoietic stem cell transplantation for lymphoma and myeloma in the past three decades.
Bhatt VR; Loberiza FR; Jing H; Bociek RG; Bierman PJ; Maness LJ; Vose JM; Armitage JO; Akhtari M
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):409-415.e1. PubMed ID: 25816932
[TBL] [Abstract][Full Text] [Related]
57. [Hematopoietic recovery as a function of the number of autografted CD34+ cells: a retrospective study of 66 patients with malignant hematologic diseases].
Boulassel MR; De Bruyère M; Nguyen BT; Straetmans N; Ferrant A
Acta Clin Belg; 1999 Aug; 54(4):191-6. PubMed ID: 10544508
[TBL] [Abstract][Full Text] [Related]
58. Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.
Westin GF; Dias AL; Go RS
Curr Hematol Malig Rep; 2016 Aug; 11(4):271-9. PubMed ID: 27177742
[TBL] [Abstract][Full Text] [Related]
59. Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.
Sibon D; Morschhauser F; Resche-Rigon M; Ghez D; Dupuis J; Marçais A; Deau-Fischer B; Bouabdallah R; Sebban C; Salles G; Brice P
Haematologica; 2016 Apr; 101(4):474-81. PubMed ID: 26721893
[TBL] [Abstract][Full Text] [Related]
60. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
Sachdeva RK; Sharma A; Singh S; Varma S
Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
